FDA Holds Back MDMA Psychedelic Therapy Over Safety, Efficacy Concerns

Lykos, the developer of the MDMA-assisted therapy for PTSD, called the FDA's request for more phase 3 research "deeply disappointing."

By: Gizmodo.com

Aug 11 2024
44
13332 Views

FDA Holds Back MDMA Psychedelic Therapy Over Safety, Efficacy Concerns

A company seeking to treat post-traumatic stress disorder with a combination of MDMA and talk therapy just suffered a major setback from the U.S. Food and Drug Administration.
Lykos Therapeutics, th… [+1778 chars]

A new life as a place for community at the Old Goucher mansion known as Hooper House

Climate Solutions Week: The future of food

High-Speed Jelly Launcher Destroys Toast

How ultra-processed bread took over America

How to turn the tables on food waste | Dana Gunders

Researchers Turn Skin Invisible Using Food Dye

Atlas Restaurant group set to take over historic Stevens Hardware Building downtown, details on future restaurant scant

Crop loss is a huge problem for sustainability and food security. I'm using AI and computer vision to help fix it.

Bits & Bites: Ja Rule teams up with Baltimore distillery on new whiskey, Keith Lee gets dessert

A Starbucks worker of nearly 20 years says the chain has gone from 'quirky coffee shop' to 'soulless fast food empire'

Skill of the Week: Keep Animals Out of Your Camping Food

Disney Wants Everyone to Stop Yelling About That Man Whose Wife Died

Share this page

Guest Posts by Easy Branches

anchor links ads by Easy Branches

FDA Holds Back MDMA Psychedelic Therapy Over Safety, Efficacy Concerns

Related